The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis (Q44538414)

3 December 2017

title

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis (English)

1 reference

3 December 2017

0 references

vascular calcification

1 reference

1 reference

1 reference

Takashi Akiba

1 reference

3 December 2017

Kosaku Nitta

1 reference

3 December 2017

Keiko Uchida

1 reference

3 December 2017

Akira Kawashima

1 reference

3 December 2017

Wako Yumura

1 reference

3 December 2017

Takashi Kabaya

1 reference

3 December 2017

Hiroshi Nihei

1 reference

3 December 2017

language of work or name

1 reference

1 August 2003

1 reference

American Journal of Kidney Diseases

3 December 2017

published in

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

303-309

1 reference

Accelerated atherosclerosis in prolonged maintenance hemodialysis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Arterial calcification and pathology in uremic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Mechanical Principles in Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

An increased serum level of parathyroid hormone is a risk factor for aortosclerosis in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Serum levels of macrophage colony-stimulating factor and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Impact of aortic stiffness on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Soluble osteopontin and vascular calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Arterial stiffening and vascular calcifications in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Factors associated with calcification of the abdominal aorta in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Serum osteoprotegerin and renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900655-3

7 January 2021

10.1016/S0272-6386(03)00655-3

Identifiers

DOI

1 reference

release_2mp42kauwbdk7kt4h6lhkab22e

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2mp42kauwbdk7kt4h6lhkab22e

24 November 2022

mapped directly with Wikidata item

1 reference